Related Experiment Video
Updated: May 12, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Anti-NMDAR Autoimmune Encephalitis: A Diagnostic Challenge in Clinical Laboratories
Patricia Ramos Mayordomo1, Lourdes Martín Rodríguez1, Nuria Alonso Castillejos1
1Department of Clinical Analysis, Hospital Universitario Río Hortega, Valladolid, Castilla y León, Spain.
Abstract:
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an antibody-mediated neurological disease which is acute, severe and with a complicated differential diagnosis. In 38% of cases, it arises as a paraneoplastic neurological syndrome (PNS) associated with cancer. Ovarian teratomas are the most frequently associated tumors, especially in young women. However, teratomas are usually mature and benign and psychiatric and neurological symptoms improve after resection. Clinical laboratories play a key role in the diagnosis and prognosis of these diseases, highlighting the importance of laboratory test results to prompt the search for the associated tumor. In addition, communication between laboratory medicine specialists and clinicians, as well as a multidisciplinary approach, are essential for early disease identification and treatment.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology